Related Experiment Video

Updated: Aug 11, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

[Oxaliplatin and genito-urinary tumors]

Stéphane Culine1

  • 1CRC Val d'Aurelle, Parc Euromédecine, 34298 Montpellier Cedex 5. stculine@valdorel.fnclcc.fr

Bulletin Du Cancer
|February 18, 2006
PubMed

Insights

Oxaliplatin is not approved for genitourinary tumors and should be limited to clinical trials. Ongoing research suggests potential in treating metastatic germ cell and bladder cancers when cisplatin is unsuitable.

Area of Science:

  • Oncology
  • Genitourinary Cancer Treatment

Background:

  • Oxaliplatin is an emerging chemotherapeutic agent.
  • Its application in genitourinary (GU) malignancies requires further investigation.

Purpose of the Study:

  • To evaluate the current status and future directions for oxaliplatin in GU tumors.
  • To identify specific patient populations within GU cancers where oxaliplatin may offer therapeutic benefit.

Main Methods:

  • Review of prospective clinical studies involving oxaliplatin in GU cancer.
  • Analysis of treatment outcomes for metastatic germ cell tumors and bladder cancer.

Main Results:

  • Oxaliplatin currently lacks marketing approval for genitourinary tumors, necessitating its use within clinical trials.
  • Prospective data indicate potential efficacy as a first-line treatment for poor-prognosis metastatic germ cell tumors.
  • Oxaliplatin shows promise for metastatic bladder cancer patients ineligible for cisplatin-based therapy.

Conclusions:

  • Restrict oxaliplatin use to clinical trials for genitourinary tumors until further approvals.
  • Continue research and development of oxaliplatin for specific GU cancer indications, particularly in poor-prognosis metastatic germ cell tumors and cisplatin-ineligible bladder cancer.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...